# Carlyle Secured Lending, Inc.: overview

CGBD · Nasdaq · CIK 1544206 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cgbd.md) · [Financials](/companies/cgbd/financials.md) · [Filings](/companies/cgbd/filings.md) · [Insiders](/companies/cgbd/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.35](/filings/0001544206-25-000077.md) | not reported | [0.25](/filings/0001544206-26-000033.md) | [0.20](/filings/0001544206-26-000055.md) | [0.33](/filings/0001544206-25-000077.md) | not reported | [(0.06)](/filings/0001544206-26-000033.md) | [0.00](/filings/0001544206-26-000055.md) |
| Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [2.69](/filings/0001544206-24-000012.md) | [1.49](/filings/0001544206-25-000011.md) | [1.64](/filings/0001544206-26-000013.md) | [1.58](/filings/0001544206-26-000013.md) | [1.01](/filings/0001544206-26-000013.md) |
| Free cash flow | $ | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cgbd/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Creative Planning](/funds/1540235.md) | 2026-06-30 | $32.5m | 3,086,927 |  | Reduced −145,059 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $29.5m | 2,799,104 |  | Added +164,323 |
| [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $18.4m | 1,748,836 |  | Added +436,365 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $14.7m | 1,395,189 |  | Added +158,636 |
| [CHOREO, LLC](/funds/1679031.md) | 2026-06-30 | $14.3m | 1,361,251 |  | Reduced −26,973 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $12.5m | 1,184,888 |  | Reduced −125,935 |
| [Lalia Capital, LLC](/funds/2106818.md) | 2026-06-30 | $9.8m | 927,333 |  | New +927,333 |
| [Russell Investments Group, Ltd.](/funds/1692234.md) | 2026-06-30 | $9.2m | 870,513 |  | Added +283,330 |
| [Muzinich & Co., Inc.](/funds/1618824.md) | 2026-06-30 | $7.8m | 741,278 |  | Added +3,534 |
| [North Ground Capital](/funds/2055446.md) | 2026-06-30 | $6.5m | 616,000 |  | Added +228,482 |

## Recent filings

[All 665 filings](/companies/cgbd/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 20:11 ET | [8-K](/filings/0001544206-26-000058.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001544206-26-000058 |
| 2026-08-06 | 20:03 ET | [10-Q](/filings/0001544206-26-000055.md) | Quarterly report, period 2026-06-30 | 0001544206-26-000055 |
| 2026-08-06 | 20:02 ET | [8-K](/filings/0001544206-26-000056.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001544206-26-000056 |
| 2026-07-15 | 20:01 ET | [8-K](/filings/0001544206-26-000045.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001544206-26-000045 |
| 2026-06-11 | 20:07 ET | [8-K](/filings/0001544206-26-000042.md) | 5.07 Shareholder vote results | 0001544206-26-000042 |
| 2026-06-11 | 20:05 ET | [8-K](/filings/0001544206-26-000040.md) | 5.07 Shareholder vote results | 0001544206-26-000040 |
| 2026-05-11 | 10:07 ET | [10-Q](/filings/0001544206-26-000033.md) | Quarterly report, period 2026-03-31 | 0001544206-26-000033 |
| 2026-05-11 | 10:01 ET | [8-K](/filings/0001544206-26-000032.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001544206-26-000032 |
| 2026-04-30 | 20:27 ET | [DEF 14A](/filings/0001544206-26-000025.md) | Proxy statement, period 2026-04-30 | 0001544206-26-000025 |
| 2026-04-30 | 20:02 ET | [DEF 14A](/filings/0001544206-26-000023.md) | Proxy statement, period 2026-04-30 | 0001544206-26-000023 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001544206-26-000013.md), filed Feb 24, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1544206
- Tickers: CGBD
- Exchange: Nasdaq
- SIC code: not reported
- State of incorporation: MD
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.